News Release
CBIO files 2023Q1 10-Q (quarterly report)
Please be advised that Catalyst Biosciences, Inc. (CBIO), one of our affiliates, filed fiscal year 2023’s first quarter 10-Q (quarterly report) to SEC today.
For more details, please refer to the link below.
https://www.sec.gov/ix?doc=/Archives/edgar/data/1124105/000156459023007276/cbio-10q_20230331.htm
This document is a press release material created purely for the purpose of publicly disclosing CBIO’s official filing with SEC and NOT for the purpose of soliciting investment either in Japan or overseas.